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The results In human bone raarrow transplantation are
s t i l l not fully satisfactory. Despite the selection
of HLA identical siblings as bone marrow donors £or
patients with severe aplastlc anemia or nematologic
tualignancies, Graf t-versus—Host Disease (GvHD)
occurs in approximately 20-70% of the patients de-
pending on their age. This complicatioa can be
caused by disparity for the products of minor Histo-
compatibility (miaor H) Systems.
Previously, we reported on the presence of cytotoxic
Τ lymphocytes (CTLs) in a patient sufferitig from
severe chronic GvHD. Those CTLs, which were
deraonstrated fronx two months after bone marrow
grafting onwards, were directed against patient's
own pre-transplant lyraphocytes. Analysis of the in
vitro cytotoxic activity of the patient's
posc-transplant lymphocytes deraonstrated the presen-
ce of a minor Η antigen of which the recognition was
HLA restricted (Goulmy et a l . 1982).
This observation prompted us to continue our search
for minor Η antigens and their role in bone marrow
transplantation. We investigated post—transplant
lymphocytes frora a series (n=19) of recipients of
HLA identical bone marrow grafts for the presence of
anci-host cytotoxic activity. Such CTL activity
could be detected post bone marrow transplant in
five patients suffering from GvHD, but was absent in
patients without GvHD (for review See: Goulmy 1985).
Further analysis of the cytotoxic activity patterns
of the post-transplant lymhocytes of the la t ter five
patients, revealed five different CTL populations
each directed against different minor Η antigens.
Four of the five rainor Η antignes were recognized in
an HLA restricted fashion (Goulmy 1985). Expansion
of the five CTL populations provided us with large
amounts of cellular typing reagents specific for
these minor Η antigens.
In order to obtain Information about the relevance
of rainor Η antigens in ehe pathogenesis of GvHD, we
performed an re trospect tve typing analysis for these
five different minor Η antigens, on a series of HLA
identical bone raarrow donor/reeipient corabinations
(n=47).
The results of this analysis (see table) demonstrate
that incompatibilities for one (or more) minor Η an-
tigens between HLA identical donor and reclpient
were found in the group of patients suffering from
GvHD. Consequently, when more than one bone raarrow
donor is available, cellular typing for minor Η an—
tigens may be helpful in avoiding one of the risk
factors for GvHD.
Table. Cellular typing of human minor Η antigens
with minor Η antigen specific CTLs.
Donor/reclpient pairs Typing for 5 minor
Η antigens
identical non-identical
recipients without GvHD
recipients with acute GvHD
recipients with chronic GvHD
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